申请人:Kitamura Shuji
公开号:US20090286791A1
公开(公告)日:2009-11-19
The present invention provides compounds represented by the formula (Ia):
the formula (Ib):
the formula (Ic):
and the formula (Id):
wherein each symbol is as defined in the specification.
According to the present invention, these compounds have a DGAT inhibitory activity and are useful for the prophylaxis, treatment or improvement of diseases or pathologies caused by high expression or high activation of DGAT.
本发明提供的化合物由以下公式(Ia)、(Ib)、(Ic)和(Id)表示,其中每个符号如规范中所定义。根据本发明,这些化合物具有DGAT抑制活性,并且对于预防、治疗或改善由高表达或高活性的DGAT引起的疾病或病理状况是有用的。